Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C30H37N3O7S.ClH |
| Molecular Weight | 620.157 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=C(NS(C)(=O)=O)C=C(C=C1NC(=O)C(=O)C2=C3C=CC=CC3=C(OCCN4CCOCC4)C=C2)C(C)(C)C
InChI
InChIKey=ICIJBYYMEBOTQP-UHFFFAOYSA-N
InChI=1S/C30H37N3O7S.ClH/c1-30(2,3)20-18-24(28(38-4)25(19-20)32-41(5,36)37)31-29(35)27(34)23-10-11-26(22-9-7-6-8-21(22)23)40-17-14-33-12-15-39-16-13-33;/h6-11,18-19,32H,12-17H2,1-5H3,(H,31,35);1H
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals. | 2012-02-15 |
|
| Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. | 2011-01 |
|
| Targeting HCV entry for development of therapeutics. | 2010-08 |
|
| Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. | 2009-12 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1252679-52-9
Created by
admin on Mon Mar 31 21:15:05 GMT 2025 , Edited by admin on Mon Mar 31 21:15:05 GMT 2025
|
PRIMARY | |||
|
56843466
Created by
admin on Mon Mar 31 21:15:05 GMT 2025 , Edited by admin on Mon Mar 31 21:15:05 GMT 2025
|
PRIMARY | |||
|
J4RA8K2Q2A
Created by
admin on Mon Mar 31 21:15:05 GMT 2025 , Edited by admin on Mon Mar 31 21:15:05 GMT 2025
|
PRIMARY | |||
|
DB05157
Created by
admin on Mon Mar 31 21:15:05 GMT 2025 , Edited by admin on Mon Mar 31 21:15:05 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
